Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.

Denis-Claude Roy, MD, Silvy Lachance, MD, Thomas Kiss, MD, Sandra Cohen, MD, Lambert Busque, MD, Douglas Fish, MD, Guy Sauvageau, MD, PhD, Maarten Egeler, MD, Jean Roy, MD

Blood (2009) 114 (22): 512.

https://doi.org/10.1182/blood.V114.22.512.512

Published: 2009

Journal Articles

Phase I Clinical Trial of Haplotype Mismatched Myeloablative Stem Cell Transplantation: Higher Doses of Donor Lymphocyte Infusions Depleted of Alloreactive Cells Using ATIR May Improve Outcome without Causing GVHD.

Denis-Claude Roy, MD, Sandra Cohen, MD, Lambert Busque, MD, Douglas Fish, MD, Thomas Kiss, MD, Silvy Lachance, MD, Guy Sauvageau, MD, Pierre Caudrelier, MD, Jean Roy, MD

Blood (2007) 110 (11): 2976.

https://doi.org/10.1182/blood.V110.11.2976.2976

Published: 2007

Journal Articles

Phase I Clinical Study of Donor Lymphocyte Infusion Depleted of Alloreactive T Cells after Haplotype Mismatched Myeloablative Stem Cell Transplantation To Limit Infections and Malignant Relapse without Causing GVHD.

Denis-Claude Roy, MD, Sandra Cohen, MD, Lambert Busque, MD, Douglas Fish, MD, Thomas Kiss, MD, Silvy Lachance, MD, Guy Sauvageau, MD, Pierre Caudrelier, MD, Jean Roy, MD

Blood (2006) 108 (11): 309.

https://doi.org/10.1182/blood.V108.11.309.309

Published: 2006

Journal Articles

A Phase I Study with Long-Term Follow-Up of Autologous Stem Cell Transplantation Using Photodynamic Treatment of Marrow Grafts for Relapsed/Refractory Acute Leukemia.

David Allan, MD, Robert Belanger, MD, Lambert Busque, MD, Douglas Fish, MD, Jeannine Kassis, MD, Jean Roy, MD, Claude Perreault, MD, Denis-Claude Roy, MD

Blood (2005) 106 (11): 2201.

https://doi.org/10.1182/blood.V106.11.2201.2201

Published: 2005

Journal Articles

Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model

Sherrill J. Slichter, Douglas Fish, V. Kraig Abrams, Lakshmi Gaur, Karen Nelson, Doug Bolgiano

Blood (2005) 105 (2): 847–854.

https://doi.org/10.1182/blood-2003-08-2942

Published: 2005

NARROW

Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.

Phase I Clinical Trial of Haplotype Mismatched Myeloablative Stem Cell Transplantation: Higher Doses of Donor Lymphocyte Infusions Depleted of Alloreactive Cells Using ATIR May Improve Outcome without Causing GVHD.

Phase I Clinical Study of Donor Lymphocyte Infusion Depleted of Alloreactive T Cells after Haplotype Mismatched Myeloablative Stem Cell Transplantation To Limit Infections and Malignant Relapse without Causing GVHD.

A Phase I Study with Long-Term Follow-Up of Autologous Stem Cell Transplantation Using Photodynamic Treatment of Marrow Grafts for Relapsed/Refractory Acute Leukemia.

Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model

Email alerts

ASH Publications

American Society of Hematology

Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.

Phase I Clinical Trial of Haplotype Mismatched Myeloablative Stem Cell Transplantation: Higher Doses of Donor Lymphocyte Infusions Depleted of Alloreactive Cells Using ATIR May Improve Outcome without Causing GVHD.

Phase I Clinical Study of Donor Lymphocyte Infusion Depleted of Alloreactive T Cells after Haplotype Mismatched Myeloablative Stem Cell Transplantation To Limit Infections and Malignant Relapse without Causing GVHD.

A Phase I Study with Long-Term Follow-Up of Autologous Stem Cell Transplantation Using Photodynamic Treatment of Marrow Grafts for Relapsed/Refractory Acute Leukemia.

Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only